The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer. The combination of immunotherapy (Tecentriq) and chemotherapy (Abraxane) was given accelerated approval for triple-negative breast cancer that is locally advanced or has spread, cannot be surgically removed, and has cells that have a protein called PD-L1, CNN… Read More »
A study has found that acupressure could be a low-cost, DIY solution for a set of persistent side effects which remain after conventional treatment for breast cancer is completed. It was reported by researchers in 2016 that acupressure helped with a reduction of fatigue in breast cancer survivors. This current study examined how acupressure impacted… Read More »
November 7, 2018 Posted By Categories Mary Chris Jaklevic is a reporter-editor at HealthNewsReview.org. She tweets as @mcjaklevic. Wake me when it’s over. There was a lot of misleading information in news stories this week about a study of sleep traits and risk of breast cancer. It was a complex study to decipher, but instead… Read More »